| Released | Contributor | Author | Title | Pages | Price |
| 10-Dec-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Industry Report for BIOTECHNOLOGY | 18 |
$49 |
| 7-Dec-2009 | Reuters Investment Profile |
N/A
| SCOLR Pharma Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. | 12 |
$20 |
| 7-Dec-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Detailed Valuation Report for DDD | 13 |
$25 |
| 5-Dec-2009 | TheStreet.com Ratings |
N/A
| TheStreet.com Ratings Stock Report For: SCOLR PHARMA INC | 5 |
$25 |
| 5-Dec-2009 | Wright Reports |
N/A
| Wright Investors Service Comprehensive Report for Scolr Pharma, Inc. | 41 |
$65 |
| 4-Dec-2009 | Pechala's Reports | Frantisek Pechala | SCOLR PHARMA INC (DDD=US) 12-months forecast | 1 |
$15 |
| 4-Dec-2009 | Pechala's Reports | Lubomir Pechala | SCOLR PHARMA INC (DDD=US) 2-weeks forecast | 1 |
$10 |
| 3-Dec-2009 | Ford Investor Services, Inc. |
N/A
| Industry Value Graph: AIS , APPA , CPRX , NLTX , NBY , PCYC , VRUS , DDD -- DRUGS | 3 |
$4 |
| 3-Dec-2009 | Ford Investor Services, Inc. |
N/A
| Value Graph: SCOLR PHARMA -- DDD | 1 |
$4 |
| 1-Dec-2009 | EconomicInvestor |
N/A
| "The Economy Matters" Report for DDD: the economy's impact on DDD's price and risk, featuring the powerful EconomicInvestor Star Rating | 6 |
$15 |
0.63% Nasdaq 
0.03%
Research Reports
